Santa Barbara, CA /PRNewswire/ - QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB), a leading provider of enterprise software and services designed for global manufacturing companies, today announced that PROCEPT BioRobotics, a Silicon Valley robotics company developing intelligent surgical solutions to treat prostate disease, has selected QAD Cloud ERP. QAD offers a unique, full-featured, cloud ERP solution for life sciences, which helps to reduce its customers' time to validation and cGMP compliance risk.
PROCEPT BioRobotics plans to implement QAD Cloud ERP at its Redwood City, California headquarters before the end of 2017. The company will work with QAD partner Strategic Information Group to execute the life sciences validation processes.
According to PROCEPT BioRobotics Vice President of Operations Eric Steuben, the company sought an effective and efficient ERP solution from a partner with extensive life sciences experience. After evaluating the competition, PROCEPT BioRobotics chose QAD Cloud ERP for a number of reasons including:
"We selected QAD Cloud ERP as our company's first ERP system to enable our team to deliver high-quality products on time with excellent customer service. As we grow, QAD Cloud ERP will be instrumental in managing our manufacturing, distribution and financials in a highly regulated environment," Steuben said. "Having QAD in the cloud will free up our IT staff and allow us to focus on our core competency of developing and manufacturing intelligent surgical solutions to improve the quality of life of men suffering from prostate disease."
With more than 400 life sciences manufacturing sites live in over 60 countries, QAD has a proven record of providing effective solutions for global medical device manufacturers.
"This adds to the list of exciting new medical device companies that have chosen QAD Cloud ERP Life Sciences Edition," said QAD Senior Vice President, North America Ed Boclair. "Medical device companies like PROCEPT BioRobotics face a number of unique challenges and a strict regulatory environment that we are supremely qualified to help them navigate."
About PROCEPT BioRobotics
Based in Silicon Valley, PROCEPT BioRobotics is enabling better patient care by developing robotic surgical solutions to treat prostate disease. With an initial focus on benign prostatic hyperplasia (BPH), the company has developed the AquaBeam System, which leverages the company's core Aquablation technology. Aquablation is a precise and controlled waterjet ablation therapy that enables heat-free and immediate removal of prostate tissue. The AquaBeam System is available for investigational use only in the U.S. and not currently available for sale in the U.S. or Canada. The AquaBeam System has received CE Mark certification and will be available in select global markets in 2017. www.procept-biorobotics.com
About QAD – The Effective Enterprise
QAD Inc. (Nasdaq: QADA) (Nasdaq: QADB) is a leading provider of enterprise software and services designed for global manufacturing companies. For more than 35 years, QAD has provided global manufacturing companies with QAD Enterprise Applications, an enterprise resource planning (ERP) system that supports operational requirements, including financials, manufacturing, demand and supply chain planning, customer management, business intelligence and business process management. QAD Enterprise Applications is offered in flexible deployment models in the cloud, on-premise or in a blended environment. With QAD, customers and partners in the automotive, consumer products, food and beverage, high technology, industrial products and life sciences industries can better align daily operations with their strategic goals to meet their vision of becoming more Effective Enterprises.
For more information about QAD, call +1 805-566-6000, visit http://www.qad.com.
"QAD" is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.
Note to Investors: This press release contains certain forward-looking statements made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding projections of revenue, income and loss, capital expenditures, plans and objectives of management regarding the Company's business, future economic performance or any of the assumptions underlying or relating to any of the foregoing. Forward-looking statements are based on the company's current expectations. Words such as "expects," "believes," "anticipates," "could," "will likely result," "estimates," "intends," "may," "projects," "should," "would," "might," "plan" and variations of these words and similar expressions are intended to identify these forward-looking statements. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to: risks associated with our cloud service offerings, such as defects and disruptions in our services, our ability to properly manage our cloud service offerings, our reliance on third-party hosting and other service providers, and our exposure to liability and loss from security breaches; demand for the company's products, including cloud service, licenses, services and maintenance; pressure to make concessions on our pricing and changes in our pricing models; protection of our intellectual property; dependence on third-party suppliers and other third-party relationships, such as sales, services and marketing channels; changes in our revenue, earnings, operating expenses and margins; the reliability of our financial forecasts and estimates of the costs and benefits of transactions; the ability to leverage changes in technology; defects in our software products and services; third-party opinions about the company; competition in our industry; the ability to recruit and retain key personnel; delays in sales; timely and effective integration of newly acquired businesses; economic conditions in our vertical markets and worldwide; exchange rate fluctuations; and the global political environment. For a more detailed description of the risk factors associated with the company and factors that may affect our forward-looking statements, please refer to the company's latest Annual Report on Form 10-K and, in particular, the section entitled "Risk Factors" therein, and in other periodic reports the company files with the Securities and Exchange Commission thereafter. Management does not undertake to update these forward-looking statements except as required by law.
SOURCE: QAD Inc.Copyright 2017 PR Newswire. All Rights Reserved